NCT02029625View on ClinicalTrials.gov

Compare the Pharmacokinetics of NVP-1205 and Coadministration of Rosuvastatin and Ezetimibe

PHASE1CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Dyslipidemia
Interventions
DRUG

NVP-1205

rosuvastatin/ezetimibe fixed dose combination orally, once daily on Period 1 or Period 2

DRUG

rosuvastatin and ezetimibe

coadministration of rosuvastatin and ezetimibe orally, once daily on Period 1 or Period 2

Trial Locations (1)

700-721

Kyungpook National Hospital, Jung-gu

Sponsors

Lead Sponsor

NVP Healthcare
All Listed Sponsors
lead

NVP Healthcare

INDUSTRY